- Home
- DAWN vs YALA Comparison
DAWN vs YALA Comparison
Compare DAWN & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAWN | YALA |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DAWN | YALA |
|---|---|---|
| Price | $11.33 | $6.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $27.56 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 337.6K |
| Earning Date | 02-24-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.79 |
| EPS | N/A | ★ 0.82 |
| Revenue | $133,672,000.00 | ★ $348,904,940.00 |
| Revenue This Year | $17.88 | $3.07 |
| Revenue Next Year | $52.38 | $11.99 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | ★ 31.11 | 5.80 |
| 52 Week Low | $5.64 | $3.83 |
| 52 Week High | $13.20 | $9.29 |
Technical Indicators
Market Signals| Indicator | DAWN | YALA |
|---|---|---|
| Relative Strength Index (RSI) | 55.26 | 44.22 |
| Support Level | $11.00 | $6.96 |
| Resistance Level | $11.84 | $7.32 |
| Average True Range (ATR) | 0.92 | 0.19 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 43.75 | 48.01 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.